Preventive behaviors for COVID-19 in Chile: Lessons from a population follow-up for 2021 and 2022

Estudios originales

Published on 11 de noviembre de 2024 | http://doi.org/10.5867/medwave.2024.10.2939

Preventive behaviors for COVID-19 in Chile: Lessons from a population follow-up for 2021 and 2022

Bivariate analysis of preventive measures score, sociodemographic, and health factors, years 2021 and 2022, Chile.*.

		Year 2021				Year 2022
Variable		n	Median	IQR	p-value	n	Median	IQR	p-value
City (n = 386)	Coquimbo	184	18	17 to 19	0.00	184	19	18 to 20	0.54
City (n = 386)	Talca	202	19	17 to 20		202	19	18 to 20
Gender (n = 386)	Male	126	18	17 to 19	0.03	126	19	17 to 20	0.05
Gender (n = 386)	Female	260	19	17 to 20		260	19	18 to 20
Health insurance (n = 365)	Public Insurance	313	18	17 to 20	0.57	313	19	18 to 20	0.18
Health insurance (n = 365)	Private Insurance	52	18	17 to 19.5		52	20	18 to 20
Age (n = 386)	7 to 19	42	17	16 to 19	0.00	42	18	16 to 19	0.00
	20 to 29	41	17	16 to 18		41	18	17 to 20
	30 to 49	111	19	18 to 20		111	20	18 to 20
	50 to 59	67	19	17 to 20		67	19	18 to 20
	60 and above	125	19	17 to 20		125	19	18 to 20
Ethnicity (n = 386)	No	360	19	17 to 20	0.10	360	19	18 to 20	0.56
Ethnicity (n = 386)	Yes	26	18	16 to 19		26	19	17 to 20
Education at age 18 or older (n = 351)	Elementary and lower	52	19	18 to 20	0.57	52	19	18 to 20	0.38
	Secondary	187	18	17 to 20		187	19	18 to 20
	Technical	34	18,5	18 to 20		34	20	18 to 20
	Professional	78	19	17 to 20		78	19	18 to 20
In-person work (n = 386)	No	99	19	17 to 20	0.30	195	19	18 to 20	0.03
In-person work (n = 386)	Yes	287	18	17 to 20		191	19	17 to 20
Healthcare worker (2021, n = 287; 2022, n = 191)	No	282	18	17 to 20	0.16	179	19	17 to 20	0.75
Healthcare worker (2021, n = 287; 2022, n = 191)	Yes	5	19	19 to 20		12	19,5	18 to 20
Episodes of illness (n = 386)	No	237	18	17 to 20	0.80	209	19	18 to 20	0.09
Episodes of illness (n = 386)	Yes	149	18	17 to 19		177	19	18 to 20
Number of episodes (2021, n = 149; 2022, n = 177)	1	98	18	17 to 20	0.44	84	19	18 to 20	0.99
Number of episodes (2021, n = 149; 2022, n = 177)	2 or more	51	19	18 to 20		93	19	18 to 20
COVID diagnosis (n = 386)	No	351	19	17 to 20	0.28	298	19	18 to 20	0.67
COVID diagnosis (n = 386)	Yes	35	18	17 to 19		88	19	18 to 20
Symptomatology (n = 386)	No	320	19	17 to 20	0.24	211	19	18 to 20	0.13
Symptomatology (n = 386)	Yes	66	18	17 to 19		175	19	18 to 20
Body mass index (n = 341; (underweight not included)
	Normal	95	18	16 to 20	0.06	95	19	18 to 20	0.45
	Overweight/obesity	246	19	17 to 20		246	19	18 to 20

Comorbidity (n = 386)	No	186	18	17 to 19	0.10	153	19	17 to 20	0.04
Comorbidity (n = 386)	Yes	200	19	17 to 20		233	20	18 to 20
Tobacco (n = 386)	No	283	19	17 to 20	0.24	283	19	18 to 20	0.41
Tobacco (n = 386)	Yes	103	18	17 to 20		103	19	17 to 20
Vaccine dosage (n = 386)	No	13	18	17 to 19	0.00	6	20	20 to 20	0.00
	Basal scheme (1 or 2 doses)	191	18	17 to 19		28	18	17 to 19
	Basal scheme + 1 boosters	182	19	18 to 20		213	19	18 to 20
	Basal scheme + 2 booster					139	20	18 to 20

IQR, interquartile range.

*All responses availables were considered for each category and year.

Source: Prepared by the authors based on the results of the study.